Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 163

Similar articles for PubMed (Select 21330903)

1.

Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda.

Mills EJ, Bakanda C, Birungi J, Mwesigwa R, Chan K, Ford N, Hogg RS, Cooper C.

AIDS. 2011 Mar 27;25(6):851-5. doi: 10.1097/QAD.0b013e32834564e9.

PMID:
21330903
2.

A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.

Loutfy MR, Genebat M, Moore D, Raboud J, Chan K, Antoniou T, Milan D, Shen A, Klein MB, Cooper C, Machouf N, Rourke SB, Rachlis A, Tsoukas C, Montaner JS, Walmsley SL, Smieja M, Bayoumi A, Mills E, Hogg RS; CANOC Collaboration.

J Acquir Immune Defic Syndr. 2010 Dec;55(4):451-9.

PMID:
21105259
3.

Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.

Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS.

Antivir Ther. 2003 Oct;8(5):379-84.

PMID:
14640384
4.

Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.

Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, Nachega JB, Dybul M, Hogg RS.

Ann Intern Med. 2011 Aug 16;155(4):209-16. doi: 10.7326/0003-4819-155-4-201108160-00358. Epub 2011 Jul 18.

PMID:
21768555
5.

Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda.

Kipp W, Alibhai A, Saunders LD, Senthilselvan A, Kaler A, Konde-Lule J, Okech-Ojony J, Rubaale T.

AIDS Care. 2010 Mar;22(3):271-8. doi: 10.1080/09540120903193625.

PMID:
20390506
6.

Clinical and immunological outcomes of a national paediatric cohort receiving combination antiretroviral therapy in Uganda.

Kiboneka A, Wangisi J, Nabiryo C, Tembe J, Kusemererwa S, Olupot-Olupot P, Joffres M, Anema A, Cooper CL, Montaner JS, Mills EJ.

AIDS. 2008 Nov 30;22(18):2493-9. doi: 10.1097/QAD.0b013e328318f148.

PMID:
19005272
7.

Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.

Holkmann Olsen C, Mocroft A, Kirk O, Vella S, Blaxhult A, Clumeck N, Fisher M, Katlama C, Phillips AN, Lundgren JD; EuroSIDA study group.

HIV Med. 2007 Mar;8(2):96-104.

PMID:
17352766
8.

Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival.

Staehelin C, Rickenbach M, Low N, Egger M, Ledergerber B, Hirschel B, D'Acremont V, Battegay M, Wagels T, Bernasconi E, Kopp C, Furrer H; Swiss HIV Cohort Study.

AIDS. 2003 Oct 17;17(15):2237-44.

PMID:
14523281
9.

Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.

Palacios R, Senise J, Vaz M, Diaz R, Castelo A.

HIV Med. 2009 Mar;10(3):157-62. doi: 10.1111/j.1468-1293.2008.00665.x.

PMID:
19245537
10.

Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy.

Bakanda C, Birungi J, Mwesigwa R, Ford N, Cooper CL, Au-Yeung C, Chan K, Nachega JB, Wood E, Hogg RS, Dybul M, Mills EJ.

AIDS. 2011 Mar 13;25(5):701-5. doi: 10.1097/QAD.0b013e3283437ed7.

PMID:
21160412
11.

The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals.

Jong E, Louw S, van Gorp EC, Meijers JC, ten Cate H, Jacobson BF.

Thromb Haemost. 2010 Dec;104(6):1228-34. doi: 10.1160/TH10-04-0233. Epub 2010 Sep 30.

PMID:
20886182
12.

CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.

Khanna N, Opravil M, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Weber R, Hirschel B, Battegay M, Kaufmann GR; Swiss HIV Cohort Study.

Clin Infect Dis. 2008 Oct 15;47(8):1093-101. doi: 10.1086/592113. Erratum in: Clin Infect Dis. 2009 May 15;48(10):1491.

13.

Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda.

Sempa J, Ssennono M, Kuznik A, Lamorde M, Sowinski S, Semeere A, Hermans S, Castelnuovo B, Manabe YC.

BMC Public Health. 2012 Sep 4;12:736. doi: 10.1186/1471-2458-12-736.

14.

Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention.

Toro PL, Katyal M, Carter RJ, Myer L, El-Sadr WM, Nash D, Abrams EJ; MTCT-Plus Initiative.

AIDS. 2010 Feb 20;24(4):515-24. doi: 10.1097/QAD.0b013e3283350ecd.

PMID:
19996939
15.

The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.

Waters L, Mandalia S, Randell P, Wildfire A, Gazzard B, Moyle G.

Clin Infect Dis. 2008 May 15;46(10):1617-23. doi: 10.1086/587660.

16.

Increase in CD4 cell counts between 2 and 3.5 years after initiation of antiretroviral therapy and determinants of CD4 progression in India.

Rajasekaran S, Jeyaseelan L, Raja K, Vijila S, Krithigaipriya KA, Kuralmozhi R.

J Postgrad Med. 2009 Oct-Dec;55(4):261-6. doi: 10.4103/0022-3859.58929.

17.

Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.

Breton G, Lewden C, Spire B, Salmon D, Brun-V├ęzinet F, Duong M, Allavena C, Leport C, Salamon R; APROCO COPILOTE ANRS CO8 Study Group.

HIV Med. 2007 Apr;8(3):164-70.

PMID:
17461860
18.

"Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy.

Wood E, Hogg RS, Yip B, Tyndall MW, Sherlock CH, Harrigan RP, O'Shaughnessy MV, Montaner JS.

J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):159-66.

PMID:
12045678
19.

Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.

Wolbers M, Bucher HC, Furrer H, Rickenbach M, Cavassini M, Weber R, Schmid P, Bernasconi E, Hirschel B, Battegay M; Swiss HIV Cohort Study.

HIV Med. 2008 Jul;9(6):397-405. doi: 10.1111/j.1468-1293.2008.00566.x. Epub 2008 Apr 10.

PMID:
18410354
20.

Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.

Mocroft A, Ledergerber B, Zilmer K, Kirk O, Hirschel B, Viard JP, Reiss P, Francioli P, Lazzarin A, Machala L, Phillips AN, Lundgren JD; EuroSIDA study group and the Swiss HIV Cohort Study.

AIDS. 2007 Sep 12;21(14):1867-75.

PMID:
17721094
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk